1. Cell Biology

Fusion pore regulation by cAMP/Epac2 controls cargo release during insulin exocytosis

  1. Alenka Guček
  2. Nikhil R Gandasi
  3. Muhmmad Omar-Hmeadi
  4. Marit Bakke
  5. Stein O Døskeland
  6. Anders Tengholm
  7. Sebastian Barg  Is a corresponding author
  1. Uppsala University, Sweden
  2. University of Bergen, Norway
https://doi.org/10.7554/eLife.41711
Share this article
Cite this article
  1. Alenka Guček
  2. Nikhil R Gandasi
  3. Muhmmad Omar-Hmeadi
  4. Marit Bakke
  5. Stein O Døskeland
  6. Anders Tengholm
  7. Sebastian Barg
(2019)
Fusion pore regulation by cAMP/Epac2 controls cargo release during insulin exocytosis
eLife 8:e41711.
https://doi.org/10.7554/eLife.41711
  2. Download BibTeX
  3. Download .RIS

Abstract

Regulated exocytosis establishes a narrow fusion pore as initial aqueous connection to the extracellular space, through which small transmitter molecules such as ATP can exit. Co-release of polypeptides and hormones like insulin requires further expansion of the pore. There is evidence that pore expansion is regulated and can fail in diabetes and neurodegenerative disease. Here we report that the cAMP-sensor Epac2 (Rap-GEF4) controls fusion pore behavior by acutely recruiting two pore-restricting proteins, amisyn and dynamin-1, to the exocytosis site in insulin-secreting beta-cells. cAMP elevation restricts and slows fusion pore expansion and peptide release, but not when Epac2 is inactivated pharmacologically or in Epac2-/- (Rapgef4-/-) mice. Consistently, overexpression of Epac2 impedes pore expansion. Widely used antidiabetic drugs (GLP-1 receptor agonists and sulfonylureas) activate this pathway and thereby paradoxically restrict hormone release. We conclude that Epac2/cAMP controls fusion pore expansion and thus the balance of hormone and transmitter release during insulin granule exocytosis.

Data availability

Source data file has been provided for Fig 7. All raw data are available on the Dryad Digital Repository (https://doi.org/10.5061/dryad.6b604g8).

The following data sets were generated

Article and author information

Author details

  1. Alenka Guček

    Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4453-1498

  2. Nikhil R Gandasi

    Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    Competing interests
    The authors declare that no competing interests exist.

  3. Muhmmad Omar-Hmeadi

    Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8893-7348

  4. Marit Bakke

    Department of Biomedicine, University of Bergen, Bergen, Norway
    Competing interests
    The authors declare that no competing interests exist.

  5. Stein O Døskeland

    Department of Biomedicine, University of Bergen, Bergen, Norway
    Competing interests
    The authors declare that no competing interests exist.

  6. Anders Tengholm

    Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4508-0836

  7. Sebastian Barg

    Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    For correspondence
    sebastian.barg@mcb.uu.se
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4661-5724

Funding

Swedish Research Council (2014-02575)

  • Anders Tengholm
  • Sebastian Barg

Norwegian Research Council

  • Marit Bakke

Helse-Bergen

  • Marit Bakke

Olga Jönssons stipend

  • Alenka Guček

P O Zetterlingsstiftelse

  • Alenka Guček

Swedish Research Council (2017-00956)

  • Anders Tengholm
  • Sebastian Barg

Swedich Research Council (2018-02871)

  • Anders Tengholm
  • Sebastian Barg

European Foundation for the Study of Diabetes

  • Anders Tengholm
  • Sebastian Barg

Diabetes Wellness Network Sweden

  • Anders Tengholm
  • Sebastian Barg

Swedish Diabetes Society

  • Anders Tengholm
  • Sebastian Barg

Swedish Society for Medical Research

  • Nikhil R Gandasi

Hjärnfonden

  • Sebastian Barg

NovoNordisk

  • Nikhil R Gandasi
  • Anders Tengholm
  • Sebastian Barg

Family Ernfors Foundation

  • Alenka Guček
  • Anders Tengholm
  • Sebastian Barg

European Foundation for the Study of Diabetes

  • Nikhil R Gandasi
  • Anders Tengholm
  • Sebastian Barg

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Axel T Brunger, Stanford University, United States

Ethics

Animal experimentation: This study was performed in strict accordance with European and Swedish legislation, fundamental ethical principles and approved by the Regional Ethics Board Uppsala (license number 31, 1-32).

Version history

  1. Received: September 5, 2018
  2. Accepted: April 28, 2019
  3. Accepted Manuscript published: May 17, 2019 (version 1)
  4. Accepted Manuscript updated: May 20, 2019 (version 2)
  5. Version of Record published: June 10, 2019 (version 3)

Copyright

© 2019, Guček et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,155
    views
  • 390
    downloads
  • 40
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alenka Guček
  2. Nikhil R Gandasi
  3. Muhmmad Omar-Hmeadi
  4. Marit Bakke
  5. Stein O Døskeland
  6. Anders Tengholm
  7. Sebastian Barg
(2019)
Fusion pore regulation by cAMP/Epac2 controls cargo release during insulin exocytosis
eLife 8:e41711.
https://doi.org/10.7554/eLife.41711

Share this article

https://doi.org/10.7554/eLife.41711

Categories and tags

Research organisms

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology

    Hsp47 promotes biogenesis of multi-subunit neuroreceptors in the endoplasmic reticulum

    Ya-Juan Wang, Xiao-Jing Di ... Ting-Wei Mu
    Research Article

    Protein homeostasis (proteostasis) deficiency is an important contributing factor to neurological and metabolic diseases. However, how the proteostasis network orchestrates the folding and assembly of multi-subunit membrane proteins is poorly understood. Previous proteomics studies identified Hsp47 (Gene: SERPINH1), a heat shock protein in the endoplasmic reticulum lumen, as the most enriched interacting chaperone for gamma-aminobutyric type A (GABAA) receptors. Here, we show that Hsp47 enhances the functional surface expression of GABAA receptors in rat neurons and human HEK293T cells. Furthermore, molecular mechanism study demonstrates that Hsp47 acts after BiP (Gene: HSPA5) and preferentially binds the folded conformation of GABAA receptors without inducing the unfolded protein response in HEK293T cells. Therefore, Hsp47 promotes the subunit-subunit interaction, the receptor assembly process, and the anterograde trafficking of GABAA receptors. Overexpressing Hsp47 is sufficient to correct the surface expression and function of epilepsy-associated GABAA receptor variants in HEK293T cells. Hsp47 also promotes the surface trafficking of other Cys-loop receptors, including nicotinic acetylcholine receptors and serotonin type 3 receptors in HEK293T cells. Therefore, in addition to its known function as a collagen chaperone, this work establishes that Hsp47 plays a critical and general role in the maturation of multi-subunit Cys-loop neuroreceptors.

    1. Cell Biology

    Involvement of TRPV4 in temperature-dependent perspiration in mice

    Makiko Kashio, Sandra Derouiche ... Makoto Tominaga
    Research Article

    Reports indicate that an interaction between TRPV4 and anoctamin 1 (ANO1) could be widely involved in water efflux of exocrine glands, suggesting that the interaction could play a role in perspiration. In secretory cells of sweat glands present in mouse foot pads, TRPV4 clearly colocalized with cytokeratin 8, ANO1, and aquaporin-5 (AQP5). Mouse sweat glands showed TRPV4-dependent cytosolic Ca2+ increases that were inhibited by menthol. Acetylcholine-stimulated sweating in foot pads was temperature-dependent in wild-type, but not in TRPV4-deficient mice and was inhibited by menthol both in wild-type and TRPM8KO mice. The basal sweating without acetylcholine stimulation was inhibited by an ANO1 inhibitor. Sweating could be important for maintaining friction forces in mouse foot pads, and this possibility is supported by the finding that wild-type mice climbed up a slippery slope more easily than TRPV4-deficient mice. Furthermore, TRPV4 expression was significantly higher in controls and normohidrotic skin from patients with acquired idiopathic generalized anhidrosis (AIGA) compared to anhidrotic skin from patients with AIGA. Collectively, TRPV4 is likely involved in temperature-dependent perspiration via interactions with ANO1, and TRPV4 itself or the TRPV4/ANO 1 complex would be targeted to develop agents that regulate perspiration.

    1. Cell Biology

    Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease

    Yuki Date, Yukiko Sasazawa ... Shinji Saiki
    Research Article Updated

    The autophagy-lysosome pathway plays an indispensable role in the protein quality control by degrading abnormal organelles and proteins including α-synuclein (αSyn) associated with the pathogenesis of Parkinson’s disease (PD). However, the activation of this pathway is mainly by targeting lysosomal enzymic activity. Here, we focused on the autophagosome-lysosome fusion process around the microtubule-organizing center (MTOC) regulated by lysosomal positioning. Through high-throughput chemical screening, we identified 6 out of 1200 clinically approved drugs enabling the lysosomes to accumulate around the MTOC with autophagy flux enhancement. We further demonstrated that these compounds induce the lysosomal clustering through a JIP4-TRPML1-dependent mechanism. Among them, the lysosomal-clustering compound albendazole promoted the autophagy-dependent degradation of Triton-X-insoluble, proteasome inhibitor-induced aggregates. In a cellular PD model, albendazole boosted insoluble αSyn degradation. Our results revealed that lysosomal clustering can facilitate the breakdown of protein aggregates, suggesting that lysosome-clustering compounds may offer a promising therapeutic strategy against neurodegenerative diseases characterized by the presence of aggregate-prone proteins.